Functional connectivity between the amygdala and subgenual cingulate gyrus predicts the antidepressant effects of ketamine in patients with treatment‐resistant depression
Neuropsychopharmacology Reports February 21, 2021 Tomoyuki Nakamura, Masaru Tomita, N. Horikawa et al. 29 citations
About one-third of patients with major depressive disorder have treatment-resistant depression. Of those, one-third do not respond to ketamine, a newer antidepressant. Resting-state functional MRI was tested for its ability to predict which patients with treatment-resistant depression would respond to ketamine treatment.